BerGenBio ASA Secures NOK 100 million Shareholder Loan Facility from Meteva AS
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, and Meteva AS, a 27.23% shareholder […]